Medicine’s Registration/Licensing in Developing Countries

Medicine registration and licensing in developing countries is a crucial process for ensuring access to safe, effective, and affordable medicines. While developing countries face specific challenges such as limited resources, weak infrastructure, and intellectual property issues, there have been achievements in improving access to essential medicines and developing local manufacturing capabilities. Recommendations include strengthening regulatory capacity, streamlining processes, fostering collaboration, promoting generics, addressing intellectual property concerns, and enhancing pharmacovigilance. Research in this field covers regulatory frameworks, access to medicines, generics, intellectual property, capacity building, pharmacovigilance, stakeholder perspectives, digital technologies, and local production. Implementing these recommendations and further research efforts will contribute to a stronger regulatory environment, equitable access to medicines, and improved health outcomes in developing countries.